Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

EUDA Health Holdings (EUDA) Return on Sales (2022 - 2025)

EUDA Health Holdings (EUDA) has disclosed Return on Sales for 3 consecutive years, with 1.42% as the latest value for Q4 2024.

  • Quarterly Return on Sales fell 92.0% to 1.42% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 1.42% through Dec 2024, down 92.0% year-over-year, with the annual reading at 0.56% for FY2024, 99.0% up from the prior year.
  • Return on Sales for Q4 2024 was 1.42% at EUDA Health Holdings, down from 0.5% in the prior quarter.
  • The five-year high for Return on Sales was 0.08% in Q1 2022, with the low at 1.42% in Q1 2023.
  • Average Return on Sales over 3 years is 0.82%, with a median of 0.96% recorded in 2023.
  • The sharpest move saw Return on Sales tumbled -150bps in 2023, then plummeted -92bps in 2024.
  • Over 3 years, Return on Sales stood at 0.08% in 2022, then crashed by -709bps to 0.5% in 2023, then tumbled by -183bps to 1.42% in 2024.
  • According to Business Quant data, Return on Sales over the past three periods came in at 1.42%, 0.5%, and 1.42% for Q4 2024, Q4 2023, and Q1 2023 respectively.